Notes
SIPPET = Survey of Inhibitors in Plasma-Product Exposed Toddlers
Reference
European Medicines Agency. Factor VIII medicines: no clear and consistent evidence of difference in risk of inhibitor development between classes. Internet Document : 15 Sep 2017. Available from: URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/09/news_detail_002812.jsp&mid=WC0b01ac058004d5c1
Rights and permissions
About this article
Cite this article
EMA concludes review of factor VIII medicines. Reactions Weekly 1671, 1 (2017). https://doi.org/10.1007/s40278-017-36435-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-36435-9